Schedule 13G

-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ENcLbhRE3EHDZwgFonbl9An6mriNuJyLyHvAwNYOdpchy/mLNcOJKNe4kVLXP++M pioCmZjjd5AaEkwXhZPJSg== 0001193125-11-034658.txt : 20110214 0001193125-11-034658.hdr.sgml : 20110214 20110214132834 ACCESSION NUMBER: 0001193125-11-034658 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20110214 DATE AS OF CHANGE: 20110214 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: KNIGHT SECURITIES L P CENTRAL INDEX KEY: 0001167589 IRS NUMBER: 223660471 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 525 WASHINGTON BLVD STREET 2: 23RD FLOOR CITY: JERSEY CITY STATE: NJ ZIP: 07310 BUSINESS PHONE: 8005447508 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: APPLIED NEUROSOLUTIONS INC CENTRAL INDEX KEY: 0000872947 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 391661164 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-55419 FILM NUMBER: 11604704 BUSINESS ADDRESS: STREET 1: 50 LAKEVIEW PARKWAY S STREET 2: STE 111 CITY: VERNON HILLS STATE: IL ZIP: 60061 BUSINESS PHONE: 847 573 8000 MAIL ADDRESS: STREET 1: 50 LAKEVIEW PARKWAY STREET 2: STE 111 CITY: VERNON HILLS STATE: IL ZIP: 60061 FORMER COMPANY: FORMER CONFORMED NAME: HEMOXYMED INC DATE OF NAME CHANGE: 20020820 FORMER COMPANY: FORMER CONFORMED NAME: OPHIDIAN PHARMACEUTICALS INC DATE OF NAME CHANGE: 19970714 SC 13G 1 dsc13g.htm SCHEDULE 13G Schedule 13G

13G

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Schedule 13G

(Initial Filing)

Under the Securities Exchange Act of 1934

Applied NeuroSolutions,Inc.

(Name of Issuer)

Common Stock, $.0025 value

(Title of Class of Securities)

03823Y203

(CUSIP Number)

December 31, 2010

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

x Rule 13d-1(b)

¨ Rule 13d-1(c)

¨ Rule 13d-1(d)

*	The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

SCHEDULE 13G


CUSIP NO. 03823Y203
1.	NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (entities only) Knight Capital Americas, L.P., formerly Knight Equity Markets, L.P. 22-3660471
2.	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) ¨ (b) ¨
3.	SEC USE ONLY
4.	CITIZENSHIP OR PLACE OF ORGANIZATION Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		5.	SOLE VOTING POWER 433,581
		6.	SHARED VOTING POWER Not applicable
		7.	SOLE DISPOSITIVE POWER 433,581
		8.	SHARED DISPOSITIVE POWER Not applicable
9.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 433,581
10.	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
11.	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 9.84% based on outstanding shares reported on the issuer’s 10-Q filed with the SEC for quarterly period ended Mar 31, 2010.
12.	TYPE OF REPORTING PERSON* BD

ITEM 1

(a).

Name of Issuer

Applied NeuroSolutions,Inc.

ITEM 1

(b).

Address of Issuer’s Principal Executive Offices

50 Lakeview Parkway, Suite 111, Vernon Hills, IL, 60061

ITEM 2

(a).

Names of Persons Filing

Knight Capital Americas, L.P., formerly Knight Equity Markets, L.P.

ITEM 2

(b).

Address of principal business office

545 Washington Blvd., 3^rd Floor

Jersey City, NJ 07310

ITEM 2

(c).

Citizenship

Delaware

ITEM 2

(d).

Title of Class of Securities

Common Stock

ITEM 2

(e).

CUSIP Number

03823Y203

ITEM 3.

If this statement is filed pursuant to Rules 13d-1(b), or 13(d)-2(b), check whether the person filing it is a:

(a)

Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).


ITEM 4.	Ownership

	(a)	Amount beneficially owned

		433,581

	(b)	Percent of class

		9.84%

	(c)	Number of shares as to which such person has:

		(i)	sole power to vote or to direct the vote

			433,581

		(ii)	shared power to vote or to direct the vote

			Not applicable

		(iii)	sole power to dispose or to direct the disposition of

			433,581

		(iv)	shared power to dispose or to direct the disposition of

			Not applicable

ITEM 5.	Ownership of Five Percent or Less of a Class

	Not applicable

ITEM 6.	Ownership of More than Five Percent on Behalf of Another Person

	Not applicable

ITEM 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company

	Not applicable.

ITEM 8.	Identification and Classification of Members of the Group

	Not applicable.

ITEM 9.	Notice of Dissolution of Group

	Not applicable.

ITEM 10.	Certification

	By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: February 11, 2011


Knight Capital Americas, L.P.

By:		/s/ Michael Corrao
		Michael Corrao
		Director of Compliance

-----END PRIVACY-ENHANCED MESSAGE-----